{
    "nct_id": "NCT06127979",
    "official_title": "Differential Changes in Ki67 Between Carriers and Noncarriers of BRCA2 Mutations With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-negative Breast Cancer Treated With Preoperative Endocrine Therapy",
    "inclusion_criteria": "* Postmenopausal women aged â‰¥18 years with biopsy-proven stage I-III invasive breast cancer that is ER+/HER2-\n* Scheduled to undergo upfront surgery\n* Eligible for genetic testing in accordance with National Comprehensive Cancer Network guidelines\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of breast cancer\n* Receipt of ET for risk reduction in the previous 3 months\n* Stage IV disease at presentation\n* Scheduled to undergo neoadjuvant systemic chemotherapy\n* Pregnant",
    "miscellaneous_criteria": ""
}